Peer review reports
From: Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
Original Submission | ||
---|---|---|
9 Mar 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
11 Apr 2022 | Reviewed | Reviewer Report |
22 Apr 2022 | Reviewed | Reviewer Report |
11 May 2022 | Author responded | Author comments - Ichidai Tanaka |
Resubmission - Version 3 | ||
11 May 2022 | Submitted | Manuscript version 3 |
13 May 2022 | Author responded | Author comments - Ichidai Tanaka |
Resubmission - Version 4 | ||
13 May 2022 | Submitted | Manuscript version 4 |
18 May 2022 | Reviewed | Reviewer Report |
5 Jun 2022 | Reviewed | Reviewer Report |
Resubmission - Version 5 | ||
Submitted | Manuscript version 5 | |
Publishing | ||
6 Jun 2022 | Editorially accepted | |
14 Jun 2022 | Article published | 10.1186/s12885-022-09741-8 |